Literature DB >> 31451581

Promiscuous G-Protein-Coupled Receptor Inhibition of Transient Receptor Potential Melastatin 3 Ion Channels by Gβγ Subunits.

Omar Alkhatib1, Robson da Costa2,3, Clive Gentry2, Talisia Quallo2, Stuart Bevan2, David A Andersson1.   

Abstract

Transient receptor potential melastatin 3 (TRPM3) is a nonselective cation channel that is inhibited by Gβγ subunits liberated following activation of Gαi/o protein-coupled receptors. Here, we demonstrate that TRPM3 channels are also inhibited by Gβγ released from Gαs and Gαq Activation of the Gs-coupled adenosine 2B receptor and the Gq-coupled muscarinic acetylcholine M1 receptor inhibited the activity of TRPM3 heterologously expressed in HEK293 cells. This inhibition was prevented when the Gβγ sink βARK1-ct (C terminus of β-adrenergic receptor kinase-1) was coexpressed with TRPM3. In neurons isolated from mouse dorsal root ganglion (DRG), native TRPM3 channels were inhibited by activating Gs-coupled prostaglandin-EP2 and Gq-coupled bradykinin B2 (BK2) receptors. The Gi/o inhibitor pertussis toxin and inhibitors of PKA and PKC had no effect on EP2- and BK2-mediated inhibition of TRPM3, demonstrating that the receptors did not act through Gαi/o or through the major protein kinases activated downstream of G-protein-coupled receptor (GPCR) activation. When DRG neurons were dialyzed with GRK2i, which sequesters free Gβγ protein, TRPM3 inhibition by EP2 and BK2 was significantly reduced. Intraplantar injections of EP2 or BK2 agonists inhibited both the nocifensive response evoked by TRPM3 agonists, and the heat hypersensitivity produced by Freund's Complete Adjuvant (FCA). Furthermore, FCA-induced heat hypersensitivity was completely reversed by the selective TRPM3 antagonist ononetin in WT mice and did not develop in Trpm3 -/- mice. Our results demonstrate that TRPM3 is subject to promiscuous inhibition by Gβγ protein in heterologous expression systems, primary neurons and in vivo, and suggest a critical role for this ion channel in inflammatory heat hypersensitivity.SIGNIFICANCE STATEMENT The ion channel TRPM3 is widely expressed in the nervous system. Recent studies showed that Gαi/o-coupled GPCRs inhibit TRPM3 through a direct interaction between Gβγ subunits and TRPM3. Since Gβγ proteins can be liberated from other Gα subunits than Gαi/o, we examined whether activation of Gs- and Gq-coupled receptors also influence TRPM3 via Gβγ. Our results demonstrate that activation of Gs- and Gq-coupled GPCRs in recombinant cells and sensory neurons inhibits TRPM3 via Gβγ liberation. We also demonstrated that Gs- and Gq-coupled receptors inhibit TRPM3 in vivo, thereby reducing pain produced by activation of TRPM3, and inflammatory heat hypersensitivity. Our results identify Gβγ inhibition of TRPM3 as an effector mechanism shared by the major Gα subunits.
Copyright © 2019 the authors.

Entities:  

Keywords:  DRG; G-protein beta-gamma; GPCR; TRPM3; ion channels; pain

Mesh:

Substances:

Year:  2019        PMID: 31451581      PMCID: PMC6774412          DOI: 10.1523/JNEUROSCI.0882-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

Review 1.  Signalling via the G protein-activated K+ channels.

Authors:  N Dascal
Journal:  Cell Signal       Date:  1997-12       Impact factor: 4.315

Review 2.  The G protein-coupled receptor-transient receptor potential channel axis: molecular insights for targeting disorders of sensation and inflammation.

Authors:  Nicholas A Veldhuis; Daniel P Poole; Megan Grace; Peter McIntyre; Nigel W Bunnett
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

3.  BAY60-6583 acts as a partial agonist at adenosine A2B receptors.

Authors:  Sonja Hinz; Svenja K Lacher; Benjamin F Seibt; Christa E Müller
Journal:  J Pharmacol Exp Ther       Date:  2014-03-14       Impact factor: 4.030

Review 4.  G protein modulation of voltage-gated calcium channels.

Authors:  Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2003-12       Impact factor: 25.468

Review 5.  Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors.

Authors:  Gábor Petho; Peter W Reeh
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

6.  Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro.

Authors:  M S Gold; J D Levine; A M Correa
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

7.  The action of prostaglandins on ion channels.

Authors:  Hans Meves
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

8.  G protein βγ subunits inhibit TRPM3 ion channels in sensory neurons.

Authors:  Talisia Quallo; Omar Alkhatib; Clive Gentry; David A Andersson; Stuart Bevan
Journal:  Elife       Date:  2017-08-15       Impact factor: 8.140

9.  Molecular basis of signaling specificity between GIRK channels and GPCRs.

Authors:  Kouki K Touhara; Roderick MacKinnon
Journal:  Elife       Date:  2018-12-10       Impact factor: 8.140

10.  Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603.

Authors:  Joelle Goulding; Lauren T May; Stephen J Hill
Journal:  Biochem Pharmacol       Date:  2017-10-26       Impact factor: 5.858

View more
  15 in total

Review 1.  TRPM3_miR-204: a complex locus for eye development and disease.

Authors:  Alan Shiels
Journal:  Hum Genomics       Date:  2020-02-18       Impact factor: 4.639

2.  Melatonin promotes sleep by activating the BK channel in C. elegans.

Authors:  Longgang Niu; Yan Li; Pengyu Zong; Ping Liu; Yuan Shui; Bojun Chen; Zhao-Wen Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

3.  The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability.

Authors:  Siyuan Zhao; Tibor Rohacs
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 3.493

4.  Upregulation of TRPM3 in nociceptors innervating inflamed tissue.

Authors:  Thomas Voets; Lauri Moilanen; Marie Mulier; Nele Van Ranst; Nikky Corthout; Sebastian Munck; Pieter Vanden Berghe; Joris Vriens
Journal:  Elife       Date:  2020-09-03       Impact factor: 8.140

Review 5.  TRPM3 in Brain (Patho)Physiology.

Authors:  Katharina Held; Balázs István Tóth
Journal:  Front Cell Dev Biol       Date:  2021-02-26

Review 6.  TRPM Channels in Human Diseases.

Authors:  Ivanka Jimenez; Yolanda Prado; Felipe Marchant; Carolina Otero; Felipe Eltit; Claudio Cabello-Verrugio; Oscar Cerda; Felipe Simon
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

7.  TRP channels in health and disease at a glance.

Authors:  Lixia Yue; Haoxing Xu
Journal:  J Cell Sci       Date:  2021-07-13       Impact factor: 5.235

8.  The structural basis for an on-off switch controlling Gβγ-mediated inhibition of TRPM3 channels.

Authors:  Marc Behrendt; Fabian Gruss; Raissa Enzeroth; Sandeep Dembla; Siyuan Zhao; Pierre-Antoine Crassous; Florian Mohr; Mieke Nys; Nikolaos Louros; Rodrigo Gallardo; Valentina Zorzini; Doris Wagner; Anastassios Economou; Frederic Rousseau; Joost Schymkowitz; Stephan E Philipp; Tibor Rohacs; Chris Ulens; Johannes Oberwinkler
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 12.779

Review 9.  Involvement of Neural Transient Receptor Potential Channels in Peripheral Inflammation.

Authors:  Harold A Silverman; Adrian Chen; Nigel L Kravatz; Sangeeta S Chavan; Eric H Chang
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

10.  The TRPM3 ion channel mediates nociception but not itch evoked by endogenous pruritogenic mediators.

Authors:  Balázs Kelemen; Silvia Pinto; Nawoo Kim; Erika Lisztes; Martin Hanyicska; Anita Vladár; Attila Oláh; Zsófia Pénzes; Brian Shu; Joris Vriens; Tamás Bíró; Tibor Rohács; Thomas Voets; Balázs István Tóth
Journal:  Biochem Pharmacol       Date:  2020-10-29       Impact factor: 6.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.